Maher J F
Am J Med. 1977 Apr;62(4):475-81. doi: 10.1016/0002-9343(77)90400-4.
Consideration of the interactions of drugs and dialysis must include an understanding of the mechanisms of transport during dialysis, i.e., diffusion, ultrafiltration and membrane-protein binding effects. Clearance is a function of molecular size, blood and dialysate flow, membrane area and permeability, and dialyzer support geometry. Protein binding and hematocrit decrease the in vivo clearances in comparison to those measured in vitro with aqueous solutions. The effect on the serum half-life is also determined by the distribution space and clearance by other routes. Other factors such as metabolic alterations of dialysis can affect pharmacologic activity, and the clinical response is the end product of many determinants. Numerous drugs are effectively removed by hemodialysis or at a slower rate by peritoneal dialysis, which occasionally allows considerable influx. The influence of intestinal contents on elimination rates by peritoneal dialysis is unknown. Peritoneal dialysis can be influenced considerably by vasoactive drugs.
对药物与透析相互作用的考量必须包括对透析过程中转运机制的理解,即扩散、超滤和膜蛋白结合效应。清除率是分子大小、血液和透析液流量、膜面积和通透性以及透析器支撑结构的函数。与在体外水溶液中测得的清除率相比,蛋白结合和血细胞比容会降低体内清除率。对血清半衰期的影响也取决于分布容积和其他途径的清除率。诸如透析引起的代谢改变等其他因素可影响药理活性,而临床反应是多种决定因素的最终结果。许多药物可通过血液透析有效清除,或通过腹膜透析以较慢速率清除,腹膜透析偶尔会有大量药物流入。肠道内容物对腹膜透析清除率的影响尚不清楚。腹膜透析会受到血管活性药物的显著影响。